Granite Group Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.5M Sell
5,936
-2,818
-32% -$1.12M 1.58% 12
2026
Q2
$3.17M Buy
8,754
+372
+4% +$127K 1.88% 11
2026
Q1
$2.85M Sell
8,382
-649
-7% -$231K 1.72% 14
2025
Q4
$2.96M Sell
9,031
-147
-2% -$46.6K 1.67% 14
2025
Q3
$2.59M Buy
9,178
+40
+0.4% +$11.6K 1.57% 15
2025
Q2
$2.55M Buy
9,138
+54
+0.6% +$15.3K 1.54% 14
2025
Q1
$2.83M Buy
9,084
+293
+3% +$86.5K 1.96% 5
2024
Q4
$2.29M Buy
8,791
+2,114
+32% +$627K 1.46% 15
2024
Q3
$2.15M Buy
6,677
+168
+3% +$55K 1.38% 20
2024
Q2
$2.03M Buy
6,509
+744
+13% +$219K 1.54% 19
2024
Q1
$1.64M Buy
5,765
+276
+5% +$80.8K 1.1% 23
2023
Q4
$1.51M Buy
+5,489
New +$1.5M 1.07% 24

Other funds holding AMGN

Granite Group Advisors's AMGN Position: Q3 2026 in Review

Granite Group Advisors reduced its Amgen (AMGN) stake by 32% in Q3 2026, selling an estimated $1.12M and leaving 5,936 shares worth $2.5M. The position accounts for 1.58% of the portfolio, ranked #12.

Granite Group Advisors first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $3.17M in Q2 2026. 3,022 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Granite Group Advisors held 5,936 shares of Amgen worth $2.5M as of Q3 2026.
  • Granite Group Advisors sold 2,818 Amgen shares in Q3 2026, an estimated $1.12M.
  • Amgen made up 1.58% of Granite Group Advisors's portfolio in Q3 2026, its #12 holding.
  • Granite Group Advisors first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
  • Granite Group Advisors's Amgen position peaked at $3.17M in Q2 2026.
  • 3,022 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Granite Group Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.